Article
Activity of Temocillin against KPC-Producing <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i>
31 Mar 2009
Abstract excerpt
Temocillin, a 6-α-methoxy derivative of ticarcillin, is currently approved for treatment of infections due to members of the Enterobacteriaceae in Belgium and the United Kingdom. It is stable against hydrolysis by most β-lactamases, including extended-spectrum β-lactamases (ESBLs) and AmpC-type β-lactamases, with studies reporting MICs at which 90% of bacteria are inhibited (MIC90s) between 16 and 32 μg/ml (3, 4,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
